Re: Rotavirus - New 2006 Vaccine

[Guest guest]

My middle son had and was very very sick.

Carlena

Re: Rotavirus - New 2006 Vaccine

" Virtually all children will experience rotavirus... " What a liar. None of my

four kids ever had it, or the vaccine.

Winnie

Rotavirus - New 2006 Vaccine

vaccinations

> Rotavirus - New 2006 Vaccine

>

> so they have to get it every 2 years?

> sounds like a great way to keep the money coming in

> Offit, who you always see on the news, etc, as a

> spokesperson for the safety of all vaccines, is

> co-creator of this vaccine and this is NEVER mentioned

> Huge conflict of interest

> Sheri

>

>

> " Virtually all children will experience

> rotavirus, " said Dr. Offit of The Children's

> Hospital of Philadelphia and ****co-creator of the vaccine ...*****

>

> " Among 5-year-olds in the U.S., an estimated one

> in 17 will visit the emergency room for rotavirus

> gastroenteritis, according to Merck. One out of 65 will be

> hospitalized.

> A federa

[Guest guest]

"Virtually all children will experience rotavirus..." What a liar. None of my four kids ever had it, or the vaccine.

Winnie Rotavirus - New 2006 Vaccinevaccinations > Rotavirus - New 2006 Vaccine> > so they have to get it every 2 years?> sounds like a great way to keep the money coming in> Offit, who you always see on the news, etc, as a > spokesperson for the safety of all vaccines, is > co-creator of this vaccine and this is NEVER mentioned> Huge conflict of interest> Sheri> > > "Virtually all children will experience > rotavirus," said Dr. Offit of The Children's > Hospital of Philadelphia and ****co-creator of the vaccine ...*****> > "Among 5-year-olds in the U.S., an estimated one > in 17 will visit the emergency room for rotavirus > gastroenteritis, according to Merck. One out of 65 will be > hospitalized.> A federal advisory committee on immunizations is > to decide this month whether to add RotaTeq to > the list of recommended pediatric vaccines, Merck said.> > The liquid vaccine can be given orally to infants > in three doses during regular well-baby visits to > the doctor at two, four and six months ...> > > > > Merck officials have said the vaccine is meant to > be effective for two years ...> > > Side effects of the vaccine can include diarrhea, > vomiting, ear infection, runny nose and sore throat, wheezing > and coughing."> > http://news./s/ap/20060203/ap_on_he_me/rotavirus_vaccine> > > Rotavirus Vaccine for Infants Approved> > > By ANDREW BRIDGES, Associated Press Writer 1 hour, 1 minute ago> > WASHINGTON - A new vaccine that protects infants > from rotavirus, which causes diarrhea and > dehydration and leads to hundreds of thousands of > deaths a year in developing countries, received federal approval > Friday.> RotaTeq, made by Merck & Co., in trials prevented > at least 98 percent of severe cases of > gastroenteritis, or intestinal inflammation.> > "This vaccine gives health care providers an > important new tool that can effectively prevent > an illness that affects almost all children > within the first few years of life," said Dr. > L. Goodman, director of the Food and > Drug Administration's Center for Biologics Evaluation and Research.> > In 1999, a different rotavirus vaccine, made by > Wyeth, was pulled from the U.S. market after it > was linked to a small increase in > intussusception, a rare, life-threatening > blockage or twisting of the intestine.> > Trials of Rotateq, however, indicated it did not > increase the risk of intussusception. But Merck > officials have said they would conduct a > follow-up study to track any long-term effects of > their vaccine, which has been in development since 1993.> > In the United States, the virus sickens about 2.7 > million children younger than 5, sends up to > 70,000 to the hospital and causes 20 to 70 deaths each year.> > RotaTeq is a genetically engineered, three-dose > oral vaccine that protects against five common rotavirus strains.> > Among 5-year-olds in the U.S., an estimated one > in 17 will visit the emergency room for rotavirus > gastroenteritis, according to Merck. One out of 65 will be > hospitalized.> A federal advisory committee on immunizations is > to decide this month whether to add RotaTeq to > the list of recommended pediatric vaccines, Merck said.> > The liquid vaccine can be given orally to infants > in three doses during regular well-baby visits to > the doctor at two, four and six months.> > Merck seeks to license the vaccine in more than > 50 countries. It plans trials in Africa and Asia, > where the virus is a noted killer.> > "Virtually all children will experience > rotavirus," said Dr. Offit of The Children's > Hospital of Philadelphia and co-creator of the > vaccine. "While some children experience mild > symptoms of rotavirus, infection can be severe > and lead to dehydration that can be fatal."> > Merck officials have said the vaccine is meant to > be effective for two years, because an older > child who gets rotavirus is much less vulnerable > to dehydration and other severe consequences of > the illness, and therefore less likely to need > hospitalization. Children would still probably > catch rotavirus and develop natural immunities to it.> > Friday's approval should provide a boost for > Merck, which faces thousands of lawsuits over > its Vioxx painkiller. The vaccine will cost > $62.50 a dose when ordered in 10-dose packets.> > Side effects of the vaccine can include diarrhea, > vomiting, ear infection, runny nose and sore throat, wheezing > and coughing.> > GlaxoKline's Rotarix vaccine has been > licensed in Mexico but has not yet come up for approval in the > United States.> ***********> http://www.suburbanchicagonews.com/couriernews/top/3_1_EL09_A1VIRUS_S1.htmt/> > Local doctors wary of vaccine> • Against rotavirus: Not enough data on its side effects; > illness can be fatal> > By Tom Polansek> STAFF WRITER> > A new vaccine to prevent rotavirus, which causes > particularly severe diarrhea, soon will be > available, but local doctors are not yet certain > whether they will recommend it to their patients.> > The U.S. Food and Drug Administration recently > approved the vaccine, RotaTeq, for infants > between 6 and 32 weeks old. When it arrives in > doctors' offices, it will be the only vaccine for > the potentially fatal viral infection.> > However, area pediatricians said they are worried > RotaTeq may cause harmful side effects. An > earlier vaccine for rotavirus, called RotaShield, > was pulled off the market in 1999 after it was > found to cause intussusception, a rare type of bowel obstruction.> > "I'm still thinking about it," Dr. ln Valena > of Sherman Family HealthCare in Elgin said when > asked whether she would push her patients to get > the new vaccine. "I just want to make sure > there's no complications. I'm a little bit leery about it right now.> > "> > Potentially deadly illness> > > Rotavirus is the leading cause of gastroenteritis > in young children in the United States and > worldwide, according to the Centers for Disease > Control and Prevention. Its symptoms include > severe diarrhea, vomiting, fever and dehydration.> > In the United States, the virus is responsible > for more than 400,000 doctor visits, 200,000 > emergency room visits, and between 20 and 60 > deaths each year in children younger than 5.> > In developing countries, the toll is even worse. > The CDC says rotavirus causes more than half a > million deaths worldwide each year in children younger than 5.> > "This vaccine will help reduce one of our most > common and potentially severe childhood > illnesses," said Dr. Anne Schuchat, director of > the CDC's National Immunization Program.> > Adults also can be infected with rotavirus, which > is highly contagious and can easily cause > dehydration. Valena said those suffering from it > can vomit more than 10 times in an hour and have > diarrhea more than 10 times in 30 minutes.> > She added that the odor of rotavirus diarrhea is particularly nasty.> > "It's the smelliest, stinkiest poop that you're > going to smell," she said. "You can smell it three rooms away."> > Despite the benefits of the vaccine, > Sorresso, nursing manager at South Elgin's > Associates in Pediatrics, said doctors at the > office also were concerned that it would produce negative side > effects.> "The last time they brought out something for the > rotavirus, they pulled it from the market," > Sorresso said. "We have talked about it. We want to wait and see > what happens."> > Oral vaccine> > > The vaccine is oral and approved to be > administered in three doses at 2, 4 and 6 months. > A CDC advisory committee has recommended that > infants receive all doses by 32 weeks, but the > full agency has not yet endorsed the vaccine.> > Schuchat said the CDC will "closely monitor" > RotaTeq once it goes on the market to make sure > there aren't any problems. She said the agency > plans to conduct its own study to determine > whether the vaccine causes adverse reactions.> > "It's important to remember that the known > benefits of the vaccine far outweigh any known risks," Schuchat said.> > Sorresso added that money is another part of the > equation for pediatricians deciding whether to > recommend RotaTeq. She said doctors don't know > yet whether insurance will cover the vaccine.> 03/09/06> ********> From: Binstock > > > Aside from the fact that the NEJM has accused > Merck of fraud (1), ever increasing toxins may > enhanced perceived "needs" for ever more > vaccinations. Marla Cone's book "Silent snow..." > describes a major epidemic among wild seals whose > natural food supply had become highly > toxic. Distemper killed >20,000 seals. S. > Ross and colleagues studied two groups of seals, > one fed highly toxic food similar to that eaten > by the wild seals, another group fed far less > toxic food similar to that eaten by wild seals > who had not experienced the epidemic. Ross > findings are presented in his book, "Seals, > pollution and disease: environmental > contaminant-induced immunosuppression" > (1995). Five additional Ross citations > follow the news article. A recent finding about > food toxins revealed that children who eat > organic food soon have lower levels of certain > toxins. A suggested inference is that ingesting > toxins may increase the likelihood of intestinal > pathologies, eg, rotavirus success, Clostridium > difficile success, etc. A ramificational > rationale is as follows: The more toxins, the > more likelihood of intestinal problems and the > greater their severity, thus the toxin-induced > need for rotavirus vaccine, even if from a > fraud-engulfed company such as Merck.> > > > * * * *> 1. New England Journal of Medicine Accuses Merck of Fraud> > From: News Target.com> http://www.newstarget.com/z017875.html> by is Black> Originally published February 15 2006> http://www.organicconsumers.org/politics/merck060216.cfm> * * * *> > Rotavirus Vaccine Urged for Babies> RotaTeq Recently Won FDA Approval> > By Gillis> Washington Post Staff Writer> Wednesday, February 22, 2006; A08> http://www.washingtonpost.com/wp-> dyn/content/article/2006/02/21/AR2006022101720.html> > > > > [foto] Merck & Co. Inc. tested its RotaTeq > vaccine in about 70,000 babies in 11 countries, > one of the biggest vaccine trials ever conducted. > (Merck & Co. Via Bloomberg News)> > Every healthy newborn in the United States should > receive a new vaccine designed to protect against > an intestinal germ called rotavirus, a federal > advisory panel decided yesterday as it set aside > theoretical concerns about the vaccine's safety.> > The decision means that pediatricians are likely > to recommend three doses of the oral vaccine for > nearly every child at age 2 months, 4 months and > 6 months, beginning almost immediately. The > vaccine won approval from the Food and Drug > Administration on Feb. 3, and some doctors have received > supplies of it.> > The recommendation for universal use of the > vaccine was approved at a meeting of the Advisory > Committee on Immunization Practices, the federal > panel that sets vaccination policy in the United > States. It comes nearly seven years after an > earlier rotavirus vaccine was withdrawn from the > market for causing a potentially life-threatening > form of intestinal blockage in some babies.> > Vaccine-safety advocates are urging parents to be > wary of the new vaccine because of that history. > The federal Centers for Disease Control and > Prevention and the manufacturer, Merck & Co. Inc. > of Whitehouse Station, N.J., have promised > elaborate studies to catch any safety problems. > Merck is selling the vaccine under the brand name RotaTeq.> > Merck has tested the vaccine in about 70,000 > babies in 11 countries, one of the biggest > vaccine trials ever conducted. That test ruled > out a safety problem similar to the one that > felled RotaShield, an earlier rotavirus vaccine > developed by Wyeth, a drugmaker in Madison, N.J. > But doctors said it is impossible to design a > test big enough to catch all possible side > effects that might show up once the product is used in millions > of children.> > RotaTeq "generally appears to have a better > safety profile than the earlier vaccine," said > Umesh D. Parashar, a medical epidemiologist at > the CDC. "But at the same time it's something > we'll continue to look at, and hopefully confirm absence of risk."> > RotaTeq is expected to be one of the most > expensive vaccines ever marketed, with Merck > listing it at $187.50 wholesale for the > three-dose series. That means many doctors are > likely to charge more than $300 retail, putting > the Merck product in league with Prevnar, an > expensive Wyeth vaccine that has been widely used > in the United States for five years. Prevnar, > which protects children against certain types of > pneumonia, became the first vaccine to meet the > pharmaceutical industry's standard for a > blockbuster product, with sales exceeding $1 billion a year.> > The development of such high-priced vaccines is > causing strains, particularly in state-sponsored > vaccination programs for certain low-income > children. But it is also drawing new > manufacturers into the vaccine market, which many > drug companies had abandoned in the 1980s and 1990s, citing too > little profit.> > RotaShield appeared on the market in late 1998 > but was pulled less than a year later after a > handful of babies that received it developed a > serious intestinal problem called > intussusception, a type of bowel obstruction that > occurs when the intestine folds in on itself, like a collapsing > telescope.> The problem occurs naturally, albeit rarely; it > showed up at a sharply elevated rate in babies > who received RotaShield. Intussusception is > life-threatening for some babies, though doctors can usually > treat it.> > Many people have never heard of rotavirus, but it > is one of the most common causes of childhood > illness -- many ailments that parents or > pediatricians describe as "stomach flu" are > caused by rotavirus infection. Virtually every > child in the world contracts the virus repeatedly > by age 5, gradually building immunity.> > Most children get over rotavirus at home, but at > least 55,000 American children are hospitalized > every year after becoming dehydrated from > vomiting and diarrhea associated with the > infection. Fifty to 60 of them die, but it is a > different story overseas, where babies often do > not receive good medical care and hundreds of thousands die > every year.> > RotaTeq contains live, but weakened, strains of > rotavirus designed to build immunity without causing illness.> © 2006 The Washington Post Company> > ********> Comments from NVIC> http://www.nvic.org> > BL Fisher Note:> > Infant diarrhea, properly managed, rarely fatal > in the US and children who recover from rotavirus infection have > immunity.> Merck's live rotavirus vaccine (RotaTeq) contains > five human-bovine (cow) reassortment rotaviruses. > Stanley Plotkin, M.D., Fred , D.V.M., Ph.D., > and Offit, M.D.are U.S. and international > patent holders of the vaccine. Offit and > are on the faculty of the Children's Hospital of > Philadelphia. Plotkin is also a patent holder of > the rubella vaccine and is associated with the Wistar Institute.> > By adding a diarrhea (rotavirus) vaccine to the > routine childhood vaccine schedule, American > children will now be subjected to 57 doses of 15 > vaccines by age 12. By 8 weeks old, an infant > will have received 9 doses of 8 vaccines and 8 of > those doses can be given on a single day.> > Were there long term studies of RotaTeq in > combination with 7 other vaccines? Was there an > evaluation of antibody response and adverse > events relative to genetic or other biological > differences between children? Was there any long > term follow up to determine whether there are > long term negative effects on the developing > immune system and brain of infants when they are > given RotaTeq along with 7 other vaccines on a > single day twice in the first four months of life > and once with 8 other vaccines on a single day at > age 6 months - compared to infants who receive no vaccines at all?> > The answer is no.> > ************> > The Wistar Institute Sells Partial Royalty Interest in Merck’s > ROTATEQ® to> the Royalty Fund> > (Philadelphia, PA, December 15, 2005) ­ The > Wistar Institute today announced that it has sold > a portion of its anticipated worldwide royalty > revenues from ROTATEQ to an affiliate of the > Royalty Fund for up to $45 million. ROTATEQ is a > new Merck & Co., Inc., vaccine to prevent > rotavirus infection, a highly contagious virus > that is the most common cause of severe > dehydrating diarrhea in infants and young > children. On Wednesday, December 14, 2005, the > Food and Drug Administration’s vaccines advisory > committee unanimously agreed that clinical data > from 70,000 infant Phase 3 trials supported the efficacy and > safety of ROTATEQ.> > The technology which forms the basis for the > vaccine was jointly developed by scientists at > Wistar and the Children’s Hospital of > Philadelphia in the 1980s and licensed to Merck > in 1991. The Vaccines and Related Biological > Products Advisory Committee of the Food and Drug > Administration today reviewed Merck’s application > to license ROTATEQ for sale in the U.S.> > Under the terms of the agreement with the > Royalty Fund, Wistar will receive an up-front > payment of $1 million and a second payment of up > to $44 million when ROTATEQ is marketed in the > United States. In addition, Wistar is expected to > retain all worldwide royalties on ROTATEQ sales > in excess of approximately $300 million annually. > These funds will be used to significantly > increase the organization’s endowment and support > implementation of Wistar’s strategic plan.> > > http://wistar.org/news_info/pressreleases/pr_12.15.05.html> > Sheri Nakken, R.N., MA, Hahnemannian Homeopath> Vaccination Information & Choice Network, Washington State, USA> Vaccines - > http://vaccinationdangers.wordpress.com/ > Homeopathy http://homeopathycures.wordpress.com> Vaccine Dangers, Childhood Disease Classes & > Homeopathy Online/email courses - next classes > start March 24, March 31, & April 1>

[Guest guest]

That's too bad but no reason to think the vaccine would have made a difference (not that you said that). How did he get over it? What did you do for it?

Winnie Rotavirus - New 2006 Vaccine> vaccinations > > > Rotavirus - New 2006 Vaccine> > > > so they have to get it every 2 years?> > sounds like a great way to keep the money coming in> > Offit, who you always see on the news, etc, as a > > spokesperson for the safety of all vaccines, is > > co-creator of this vaccine and this is NEVER mentioned> > Huge conflict of interest> > Sheri> > > > > > "Virtually all children will experience > > rotavirus," said Dr. Offit of The Children's > > Hospital of Philadelphia and ****co-creator of the vaccine ...*****> > > > "Among 5-year-olds in the U.S., an estimated one > > in 17 will visit the emergency room for rotavirus > > gastroenteritis, according to Merck. One out of 65 will be > > hospitalized.> > A federa> >